Hospital-level airway clearance therapy for home use.

Proven1 in the acute care setting to deliver outstanding clinical and economic outcomes, the Volara system is an OLE device that now can be used at home. Indicated for the mobilization of secretions, lung expansion therapy, and the treatment and prevention of pulmonary atelectasis, the Volara system offers 3-in-1 versatility for chronic patients.

Watch Clinician Video



Continuous Positive Expiratory Pressure treats and helps prevent pulmonary atelectasis by combining continuous positive pressure with nebulizer therapy, to help expand and hold the airways open.


Continuous High Frequency Oscillation, a pneumatic form of chest therapy, delivers continuous pulses of positive pressure combined with nebulizer therapy to mobilize retained secretions.


Integrated with CPEP and CHFO for maximum treatment efficiency, medication is delivered during therapy to help loosen secretions.


A special homecoming for Aiden.

For Aiden, who lives with a neuromuscular condition, the Volara system has made all the difference—including his first Christmas with his adoptive family. Watch his story.


OLE therapy mechanism of action.

See how the practical and flexible Volara system has the power to change lives, with 3-in-1 OLE therapy that takes just 10 minutes to deliver. Watch now.


Maximizing outcomes.

For chronic conditions:

  • Cystic fibrosis (CF)
  • Cerebral palsy (CP)
  • Amyotrophic lateral sclerosis (ALS)
  • Muscular dystrophy (MD)
  • Spinal muscular atrophy (SMA)
  • Spinal cord injuries (SCI)

With multiple delivery modes:

  • Mouthpiece
  • Face mask
  • Tracheostomy
"" play_circle_outline

MDA Industry Update Webinar: John Prpich, MD, FAAP, Pediatric Pulmonary Specialists P.A., Tampa FL

"" play_circle_outline

MDA Industry Update Webinar: Lisa Wolfe, MD, Northwestern University Feinberg School of Medicine


Explore Volara system precision and versatility features

OLE therapy has proven1 so effective in hospitals, physicians have often asked when this therapy would be available for patients in their homes. Now it is with the Volara system—including exciting advancements for accurate, consistent therapy.

Lightweight and portable

Physician-prescribed presets

Intuitive touchscreen interface

Broad range of adaptors


Proven in the hospital, now for the home.

Tested and proven1 in acute care settings, OLE therapy has been shown to provide outstanding clinical outcomes.

1.6 Days

Reduction in hospital length of stay1


Reduction in time on ventilator1

2 Days

Reduction in ICU length of stay1


Overall relative reduction in postoperative pulmonary complications.1

Want to learn more about the Volara system?

Simply complete this form and we’ll contact you for a demonstration.

  1. Huynh TT, Liesching TN, Cereda M, Lei Y, Frazer MJ, Nahouraii MR, Diette GB, Efficacy of Oscillation and Lung Expansion in Reducing Postoperative Pulmonary Complication, Journal of the American College of Surgeons (2019).
Volara is a registered trademark of Baxter International, Inc. or its subsidiaries.